MAGI2-AS3/miR-450b-5p/COLEC10 interaction network: A potential therapeutic and prognostic marker in hepatocellular carcinoma
Open Access
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82372813, 2022GZR005, 2022MS039)
- Natural Science Foundation of Shanghai Municipality (22ZR1477900)
- Science and Technology Commission of Shanghai Municipality (22QA1411600, 24YF2758600)
- Shanghai Municipal Health Commission (20224Y0299, 20244Y0233)
This publication has 51 references indexed in Scilit:
- Nur77 suppresses hepatocellular carcinoma via switching glucose metabolism toward gluconeogenesis through attenuating phosphoenolpyruvate carboxykinase sumoylationNature Communications, 2017
- Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infectionJournal of Hepatology, 2017
- CDKN3 expression is negatively associated with pathological tumor stage and CDKN3 inhibition promotes cell survival in hepatocellular carcinomaMolecular Medicine Reports, 2016
- Decreased expression of PBLD correlates with poor prognosis and functions as a tumor suppressor in human hepatocellular carcinomaOncotarget, 2015
- LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancerOncogene, 2015
- The role of hepatic resection in the treatment of hepatocellular cancerHepatology, 2015
- The multilayered complexity of ceRNA crosstalk and competitionNature, 2014
- High-sensitivity Lens culinaris agglutinin-reactive alpha-fetoprotein assay predicts early detection of hepatocellular carcinomaJournal of Gastroenterology, 2013
- Comparison of resection and ablation for hepatocellular carcinoma: A cohort study based on a Japanese nationwide surveyJournal of Hepatology, 2013
- Vascular Invasion and Histopathologic Grading Determine Outcome After Liver Transplantation for Hepatocellular Carcinoma in CirrhosisHepatology, 2001